Luprohal 22.5 Depot Combikit Injection 1's

Luprohal 22.5 Depot Combikit Injection belongs to the class of medicines called gonadotropin-releasing hormone (GnRH) agonists primarily used to treat prostate cancer and endometriosis. Additionally, it is also used to treat precocious puberty (early puberty) in children. Luprohal 22.5 Depot Combikit Injection is used in combination with other medicines to treat anaemia caused by uterine fibroids.

Luprohal 22.5 Depot Combikit Injection contains Leuprolide acetate, which is a synthetic hormone that acts similar to the GnRH, produced by the hypothalamus gland in the brain. It works by inhibiting the synthesis of the natural male hormone, testosterone in men and oestrogen in women. This process of lowering hormone levels can decrease cancer cell growth in prostate cancer and helps treat endometriosis.

Luprohal 22.5 Depot Combikit Injection will be administered by a healthcare professional. The common side effects of Luprohal 22.5 Depot Combikit Injection include hot flashes, decreased sexual interest, dizziness, headache, nausea, vomiting, diarrhoea, upset stomach and injection site reaction. These side effects are not familiar to everyone and vary individually. If you notice any side effects that are not manageable, please consult your doctor.

Avoid taking Luprohal 22.5 Depot Combikit Injection if you are pregnant or breastfeeding. Both women and men using Luprohal 22.5 Depot Combikit Injection should use effective contraception. Luprohal 22.5 Depot Combikit Injection may affect fertility, hence discuss with your doctor if you have any plans to start a family in the future. Luprohal 22.5 Depot Combikit Injection is not recommended for children below two years of age. Luprohal 22.5 Depot Combikit Injection may cause dizziness, hence drive only if you are alert.

Luprohal 22.5 Depot Combikit Injection is used in the treatment of Prostate cancer, Endometriosis, and Precocious puberty. The detailed uses of Luprohal 22.5 Depot Combikit Injection are as follows:

• Treat advanced prostate cancer: Luprohal 22.5 Depot Combikit Injection is primarily used to manage symptoms of advanced prostate cancer by lowering testosterone levels, which slows the growth of cancer cells.
• Manage endometriosis and uterine fibroids: Luprohal 22.5 Depot Combikit Injection helps reduce estrogen production, alleviating pain and other symptoms associated with endometriosis and fibroids, and may be used preoperatively to shrink fibroid size.
• Treat central precocious puberty (CPP): Luprohal 22.5 Depot Combikit Injection is prescribed for children with CPP to delay early onset of puberty and normalize growth and sexual development.
• Support fertility treatments and hormone regulation: Luprohal 22.5 Depot Combikit Injection is used in assisted reproductive technologies to control hormone levels and prevent premature ovulation during fertility procedures.
• Treat anemia caused by uterine fibroids: In combination with other medications, Luprohal 22.5 Depot Combikit Injection helps improve hemoglobin levels by reducing menstrual bleeding linked to fibroids.

• Follow your doctor's recommendations on the dosage and timing of this medication to achieve optimal results.
• Luprohal 22.5 Depot Combikit Injection will be administered by a healthcare professional.
• Do not self-administer.

Luprohal 22.5 Depot Combikit Injection contains Leuprolide acetate, a gonadotropin-releasing hormone (GnRH) agonist. It treats prostate cancer in men, endometriosis in women and precocious puberty (early puberty) in children. Luprohal 22.5 Depot Combikit Injection is a synthetic hormone that acts similar to the GnRH, produced by the hypothalamus gland in the brain. Luprohal 22.5 Depot Combikit Injection works by lowering testosterone levels in men that help stop the growth of cancer cells in prostate cancer. Luprohal 22.5 Depot Combikit Injection reduces oestrogen (a hormone required for the development and regulation of the female reproductive system and secondary sexual characteristics) levels in women, thus helping in endometriosis.

If you are allergic to Luprohal 22.5 Depot Combikit Injection or any other medicines, please tell your doctor. Luprohal 22.5 Depot Combikit Injection is not indicated for use in pregnancy and breastfeeding women. If you are using Luprohal 22.5 Depot Combikit Injection, make sure to use reliable forms of contraception. Luprohal 22.5 Depot Combikit Injection may also affect fertility in men, hence discuss with your doctor if you have any plans to start a family in the future. Luprohal 22.5 Depot Combikit Injection is not recommended for children younger than two years of age. If you have a seizure or unusual changes in mood or behaviour, inform your doctor immediately. Before starting Luprohal 22.5 Depot Combikit Injection, let your doctor know if you have liver or kidney diseases, heart diseases, recent heart attack, depression, brain tumours, electrolyte imbalance, diabetes, fits, weak bones and high cholesterol levels. Luprohal 22.5 Depot Combikit Injection may cause QT prolongation (heart muscle takes longer than normal to recharge between beats) and may affect heart rhythm, hence heart patients should be cautious while taking Luprohal 22.5 Depot Combikit Injection. Luprohal 22.5 Depot Combikit Injection can make you feel dizzy and affects your mental ability to drive. Do not drive or operate machinery if you are not mentally alert and focused.